ARTICLE | Clinical News
CerAxon citicoline: Phase III
January 17, 2000 8:00 AM UTC
Preliminary analysis of IPIC's 899-patient Phase III ECCO 2000 trial showed that CerAxon citicoline failed to meet its primary end point of improved neurological function from baseline compared to pla...